CN103494821A - 一种头孢克肟组合物 - Google Patents
一种头孢克肟组合物 Download PDFInfo
- Publication number
- CN103494821A CN103494821A CN201310470397.6A CN201310470397A CN103494821A CN 103494821 A CN103494821 A CN 103494821A CN 201310470397 A CN201310470397 A CN 201310470397A CN 103494821 A CN103494821 A CN 103494821A
- Authority
- CN
- China
- Prior art keywords
- cefixime
- aerosil
- lactose
- microcrystalline cellulose
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960002129 cefixime Drugs 0.000 title claims abstract description 32
- -1 Cefixime compound Chemical class 0.000 title abstract 3
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 claims abstract description 29
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 26
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 13
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 13
- 239000008101 lactose Substances 0.000 claims abstract description 13
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 13
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 13
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 13
- 239000000314 lubricant Substances 0.000 claims abstract description 8
- 229910002012 Aerosil® Inorganic materials 0.000 claims description 20
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 235000019359 magnesium stearate Nutrition 0.000 claims description 7
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 229910021485 fumed silica Inorganic materials 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 229940041007 third-generation cephalosporins Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 238000007907 direct compression Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009702 powder compression Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010064921 Urinary tract inflammation Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 229940124588 oral cephalosporin Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
对照例1 | 实施例1 | 实施例2 | 实施例3 | 实施例4 | |
0天 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
5天 | 0.51 | 0.3 | 0.24 | 0.19 | 0.18 |
10天 | 0.87 | 0.45 | 0.41 | 0.24 | 0.2 |
对照例1 | 实施例1 | 实施例2 | 实施例3 | 实施例4 | |
0天 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
5天 | 0.79 | 0.42 | 0.45 | 0.26 | 0.24 |
10天 | 1.25 | 0.56 | 0.51 | 0.3 | 0.29 |
对照例1 | 实施例1 | 实施例2 | 实施例3 | 实施例4 |
0天 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
5天 | 5天 | 0.49 | 0.32 | 0.3 | 0.2 |
10天 | 10天 | 0.77 | 0.4 | 0.38 | 0.26 |
对照例1 | 实施例1 | 实施例2 | 实施例3 | 实施例4 | |
0天 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
5天 | 0.71 | 0.47 | 0.55 | 0.29 | 0.28 |
10天 | 1.34 | 0.59 | 0.71 | 0.34 | 0.3 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310470397.6A CN103494821B (zh) | 2013-10-01 | 2013-10-01 | 一种头孢克肟组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310470397.6A CN103494821B (zh) | 2013-10-01 | 2013-10-01 | 一种头孢克肟组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103494821A true CN103494821A (zh) | 2014-01-08 |
CN103494821B CN103494821B (zh) | 2018-09-25 |
Family
ID=49860145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310470397.6A Active CN103494821B (zh) | 2013-10-01 | 2013-10-01 | 一种头孢克肟组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103494821B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113332441A (zh) * | 2021-05-22 | 2021-09-03 | 深圳立健药业有限公司 | 一种头孢克肟组合物及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008022836A1 (en) * | 2006-08-22 | 2008-02-28 | Evonik Degussa Gmbh | Fumed silica for use as auxiliary in pharmaceutical and cosmetic compositions |
CN101420982A (zh) * | 2006-04-13 | 2009-04-29 | 东亚药品株式会社 | 干式直压速崩片 |
WO2011078821A1 (en) * | 2009-12-25 | 2011-06-30 | Mahmut Bilgic | Effervescent tablet and granule formulation comprising cefixime |
-
2013
- 2013-10-01 CN CN201310470397.6A patent/CN103494821B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101420982A (zh) * | 2006-04-13 | 2009-04-29 | 东亚药品株式会社 | 干式直压速崩片 |
WO2008022836A1 (en) * | 2006-08-22 | 2008-02-28 | Evonik Degussa Gmbh | Fumed silica for use as auxiliary in pharmaceutical and cosmetic compositions |
WO2011078821A1 (en) * | 2009-12-25 | 2011-06-30 | Mahmut Bilgic | Effervescent tablet and granule formulation comprising cefixime |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113332441A (zh) * | 2021-05-22 | 2021-09-03 | 深圳立健药业有限公司 | 一种头孢克肟组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103494821B (zh) | 2018-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103239450A (zh) | 一种能快速溶出、稳定的孟鲁司特钠口服固体制剂及其制备方法 | |
CN102552258B (zh) | 一种含瑞格列奈的药物组合物及其制备方法 | |
JP6126456B2 (ja) | 打錠用顆粒とその製造方法、その打錠用顆粒を用いた口腔内崩壊錠 | |
JP2022538214A (ja) | ブルトン型チロシンキナーゼ阻害剤を含む経口固体錠剤及びその調製方法 | |
CN104146976A (zh) | 一种高负载丙戊酸类药物缓释片及其制备方法 | |
CN104306348A (zh) | 一种辛伐他汀片及其制备方法 | |
CN103768063B (zh) | 一种盐酸莫西沙星药物组合物及其制备方法 | |
CN102688210A (zh) | 鲁拉西酮的药物组合物和制备方法 | |
CN103610658B (zh) | 一种免疫调节剂缓释剂及其制备方法 | |
CN103127011B (zh) | 罗氟司特片及其制备方法 | |
CN103191114A (zh) | 一种含有莫西沙星的药物口服固体制剂及其制备方法 | |
CN104473892A (zh) | 一种用于直接压片的法罗培南钠组合物及其制备方法 | |
CN103006594A (zh) | 一种格列美脲组合物及其制备方法 | |
CN103494821A (zh) | 一种头孢克肟组合物 | |
CN102302466A (zh) | 一种可粉末直接压片的卡培他滨药用组合物及其应用 | |
CN101612138B (zh) | 盐酸头孢他美酯胶囊及其制备方法 | |
CN103417503A (zh) | 一种阿莫西林克拉维酸钾片剂及其制备工艺 | |
CN103705515B (zh) | 含有瑞格列奈和盐酸二甲双胍的药物组合物的制备方法 | |
CN104173310A (zh) | 一种稳定的阿莫西林片剂组合物、其制备方法及用途 | |
CN103919744A (zh) | 一种头孢特仑新戊酯片及其制备工艺 | |
CN101862325A (zh) | 一种含有坎地沙坦酯的药物组合物 | |
CN104098489A (zh) | 一种微粉化格列本脲及其组合物 | |
CN104523628A (zh) | 一种可粉末直接压片的琥珀酸索利那新片剂及其制备方法 | |
CN103315972B (zh) | 一种盐酸莫西沙星片剂及其制备方法 | |
CN105534980B (zh) | 瑞格列奈盐酸二甲双胍的药物组合物及其制剂工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160825 Address after: 264205, Weihai economic and Technological Zone, Shandong Province, Qingdao South Road, No. 1 Applicant after: Disha Pharmaceutical Industry Group Corp., Ltd. Address before: 264205, Weihai economic and Technological Zone, Shandong Province, Qingdao South Road, No. 1 Applicant before: Disha Pharmaceutical Industry Group Corp., Ltd. Applicant before: Disha Pharmaceutical Group Shandong Disha Pharmaceutical Co., Ltd. Applicant before: The husky biotechnology of Weihai enlightening Co., Ltd |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191104 Address after: 264205 No. 1 South Qingdao Road, Weihai economic and Technological Development Zone, Shandong, China Co-patentee after: Dijia Pharmaceutical Group Co., Ltd Patentee after: Disha Pharmaceutical Industry Group Corp., Ltd. Address before: 264205, Weihai economic and Technological Zone, Shandong Province, Qingdao South Road, No. 1 Patentee before: Disha Pharmaceutical Industry Group Corp., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210615 Address after: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Cefixime composition Effective date of registration: 20211025 Granted publication date: 20180925 Pledgee: Bank of China Limited Weihai Branch Pledgor: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Registration number: Y2021980010533 |